Argpyrimidine-tagged rutin-encapsulated biocompatible (ethylene glycol dimers) nanoparticles: Application for targeted drug delivery in experimental diabetes (Part 2)

International Journal of Pharmaceutics

Volumn 528, Issue 1-2, 2017, Pages 8-17

  Bhattacherjee, Abhishek ^a,b   Chakraborti, Abhay Sankar ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Advanced glycation end products; Argpyrimidine; Diabetes mellitus; Nanoparticles; Rutin; Targeted drug delivery

Indexed keywords

DIMER; MACROGOL; PYRIMIDINE DERIVATIVE; RUTOSIDE; ADVANCED GLYCATION END PRODUCT; ARGPYRIMIDINE; DRUG CARRIER; ETHYLENE GLYCOL; NANOPARTICLE; ORNITHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HYPERGLYCEMIA; HYPERLIPIDEMIA; MALE; NANOENCAPSULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DRUG CARRIERS; ETHYLENE GLYCOL; GLYCATION END PRODUCTS, ADVANCED; MALE; NANOPARTICLES; ORNITHINE; PYRIMIDINES; RATS; RATS, WISTAR; RUTIN;

EID: 85019967730     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.05.058     Document Type: Article

References (49)

1. Adebayo, J.O., Adesokan, A.A., Olatunji, L.A., Buoro, D.O., Effect of ethanolic extract of Bougainvillea spectabilis leaves on haematological and serum lipid variables in rats. Biokemistri 17 (2005), 45–50.
2. Baynes, J.W., Role of oxidative stress in development of complications of diabetes mellitus. Diabetes 40 (2004), 405–412.
3. 2+) form. Int. J. Biol. Macromol. 48 (2011), 202–209.
4. Bhattacherjee, A., Chakraborti, A.S., Inhibitory effect of Piper beatle Linn. leaf extract on protein glycation −Quantification and characterization of the antiglycation compounds. Ind. J. Biochem. Biophys. 50 (2013), 529–536.
5. Bhattacherjee, A., Dhara, K.P., Chakraborti, A.S., Argpyrimidine-tagged rutin-encapsulated biocompatible (ethylene glycol dimers) nanoparticles: synthesis, characterization and evaluation for targeted drug delivery. Int. J. Pharmaceutics 509 (2016), 507–517.
6. Bhattacherjee, A., Dhara, K.P., Chakraborti, A.S., Bimolecular interaction of argpyrimidine (a Maillard reaction product) in in vitro non-enzymatic protein glycation model and its potential role as an antiglycating agent. Int. J. Biol. Macromol. 102 (2017), 1274–1285.
7. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001), 813–820.
8. Cazarolli, L.H., Folador, P., Moresco, H.H., Brighent, I.M., Pizzolatti, M.G., Silva, F.R., Stimulatory effect of apigenin-6-C-b-L-fucopyranoside on insulin secretion and glycogen synthesis. Eur. J. Med. Chem. 44 (2009), 4668–4673.
9. Cazarolli, L.H., Pereira, D.F., Kappel, V.D., Folador, P., Figueiredo, M.D., Pizzolatti, M.G., Insulin signaling: a potential signaling pathway for the stimulatory effect of kaempferitrin on glucose uptake in skeletal muscle. Eur. J. Pharmacol. 712 (2013), 1–7.
10. Cheng, J., Teply, B.A., Sherifi, I., Sung, J., Luther, G., Gu, F.X., Levy-Nissenbaum, E., Radovic- Moreno, A.F., Langer, R., Farokhzad, O.C., Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28 (2007), 869–876.
11. Christopher, M.M., Broussard, J.D., Peterson, M.E., Heinz body formation associated with ketoacidosis in diabetic cats. J. Vet. Intern. Med. 9 (1995), 24–31.
12. Coneac, G., Gafitanu, E., Hadaruga, N.G., Hadaruga, D.I., Rivis, A., Bandur, G., Propolis extract/b-cyclodextrin nanoparticles: synthesis, physio-chemical and multivariate analyses. J. Agroaliment Proc. Technol. 14 (2008), 58–70.
13. Davis, M.E., Chen, Z.G., Shin, D.M., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Cancer 7 (2008), 771–782.
14. Deeds, M.C., Anderson, J.M., Armstrong, A.S., Gastineau, D.A., Hiddinga, H.J., Jahangir, A., Eberhardt, N.L., Kudva, Y.C., Single dose streptozotocin induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45 (2011), 131–140.
15. El-Sherbiny, I.M., Abdel-Mogib, M., Dharwar, A.A.M., Elsayed, A., Smyth, H.D.C., Biodegradable pH-responsive aliginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin. Carbohydr. Polym. 83 (2011), 1345–1354.
16. Fang, X.K., Gao, J., Zhu, D.N., Kaempferol and quercetin from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 829 (2008), 615–622.
17. Galagudza, M., Korolev, D., Postnov, V., Naumisheva, E., Grigorova, Y., Uskov, I., Shlyakhto, E., Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int. J. Nanomed. 7 (2012), 1671–1678.
18. Gomes, R., Silva, M.S., Quintas, A., Cordeiro, C., Freire, A., Pereira, P., Martins, A., Monteiro, E., Barroso, E., Freire, A.P., Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. Biochem. J. 385 (2005), 339–345.
19. Gu, F., Zhang, L., Teply, B.A., Mann, N., Wang, A., Radovic-Moreno, A.F., Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl. Acad. Sci. 105 (2008), 2586–2591.
20. Haligur, M., Topasakal, S., Ozem, O., Early degenerative effects of diabetes mellitus on pancreas, liver and kidney in rats: an immunohistochemical study. Exptl. Diabetes Res., 2012, 2012 (Article ID 120645).
21. Halliwell, B., Gutteridge, J.M.C., Free Radicals in Biology and Medicine. ed 4, 2006, Oxford University Press, New York, 77–153.
22. Harborne, J.B., Plant phenolics. Bell, E.A., Charlwood, B.V., (eds.) Encyclopedia of Plant Physiology, Vol. 8. Secondary Plant Products, 1986, Springer, Verlag, Berlin, 329–395.
23. Hoeven, K.H., Factor, S.M., A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82 (1990), 848–855.
24. Inoue, K., Wada, J., Eguchi, J., Nakatsuka, A., Teshigawara, S., Murakami, K., Ogawa, D., Terami, T., Katayama, A., Tone, A., Iseda, I., Hida, K., Yamada, M., Ogawa, T., Makino, H., Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray. PLoS One, 8, 2013, e77118.
25. 4-induced hepatotoxicity in rodents. Fitoterapia 73 (2002), 557–563.
26. Kamalakkannan, N., Prince, P.S., Antihyperglycemic and antioxidant effect of rutin a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin. Pharmacol. Toxicol. 98 (2006), 97–103.
27. King, J., The dehydrogenase of oxidoreductase-lactate dehydrogenase. Practical Clinical Enzymology, 1965, Nostrand Co, London, 83–93.
28. Lillie, R.D., Fullmer, H.M., Histopathologic Technique and Practical Histochemistry. 4th ed., 1976, Mc-Graw Hill, New York, 559–600.
29. Litwin, S.E., Raya, T.E., Anderson, P.G., Daugherty, S., Goldman, S., Abnormal cardiac function in the streptozotocin-diabetic rat: changes in active and passive properties of the left ventricle. J. Clin. Invest. 86 (1990), 481–488.
30. Lowry, O.H., Rosenbrough, N.J., Farr, A.L., Randall, R.L., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 264–275.
31. Mahmoud, A.M., Ashour, M.B., Abdel-Moneim, A., Ahmed, O.M., Hesperidin and naringenin attenuate hyperglycemic mediated oxidative stress and pro-inflammatory cytokine production in high fat fed/streptozocin-induced type 2 diabetic rats. J. Diabetes Complications 26 (2012), 483–490.
32. Maity, S., Mukhopadhyay, P., Kundu, P.P., Chakraborti, A.S., Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals–an in vitro and in vivo approach. Carbohydr. Polym. 170 (2017), 124–132.
33. Mohamed, J., Wen, H.K., Idris, M.H.M., Zainalabidin, S., Budin, S.B., Reduced red blood cell membrane damage in streptozotocin-induced diabetic rats supplemented with roselle (UKMR- 2) calyx extract. Pak. J. Biol. Sci. 17 (2014), 682–688.
34. New, J.P., Aung, T., Baker, P.G., The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study. Diabet. Med. 25 (2008), 564–569.
35. Noyan-Ashraf, M.H., Shikatani, E.A., Schuiki, I., Mukovozov, I., Wu, J., Li, R.K., Volchuk, A., Robinson, L.A., Billia, F., Drucker, D.J., Husain, M., A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 127 (2013), 74–85.
36. Okinaka, S., Kumogai, H., Ebashi, S., Sugaita, H., Momoi, H., Toyokura, Y., Fujie, Y., Serum creatine phosphokinase activity in progressive muscular dystrophy and neuromuscular disease. Arch. Neurol. 4 (2005), 520–525.
37. Roy, M., Sen, S., Chakraborti, A.S., Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats Implication for glycation-induced hemoglobin modification. Life Sci. 82 (2008), 1102–1110.
38. Santhakumari, P., Prakasam, A., Pugalendi, K.V., Antihyperglycemic activity of Piper betle leaf on streptozotocin-induced diabetic rats. J. Med. Food. 9 (2006), 108–112.
39. Sen, S., Roy, M., Chakraborti, A.S., Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J. Pharm. Pharmacol. 63 (2011), 287–296.
40. Silva, F.R., Szpoganicz, B., Pizzolatti, M.G., Willrich, M.A., De, S.E., Acute effect of Bauhinia forficate on serum glucose levels in normal and alloxan-induced diabetic rats. J. Ethnopharmacol. 83 (2002), 33–37.
41. Singh, N.P., McCoy, M.T., Tice, R.R., Schneider, E.L., A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell. Res. 175 (1998), 184–190.
42. Spivak, M.Y., Bubnov, R.V., Yemets, I.M., Lazarenko, L.M., Tymoshok, N.O., Ulberg, Z.R., Gold nanoparticles − the theranostic challenge for PPPM: nanocardiology application. EPMA J. 4 (2013), 18–24.
43. Sreejayan, N., Yang, X., Palanichamy, K., Dolence, K., Ren, J., Antioxidant properties of argpyrimidine. Eur. J. Pharmacol. 593 (2008), 30–35.
44. Stevens, P.E., Anaemia, diabetes and chronic kidney disease: where are we now?. J. Ren. Care. 38 (2012), 67–77.
45. Tang, J., Xie, Q., Pan, G., Wang, J., Wang, M., Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur. J. Cardiothorac. Surg. 30 (2006), 353–361.
46. Trinder, P., Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J. Clin. Pathol., 22, 1969, 246.
47. Vessal, M., Hemmanti, M., Vasei, M., Antidiabetic effect of quercetin in streptozotocin induced diabetic rats. Comp. Biochem. Physiol. (Part C), 135, 2003 357–354.
48. Willsky, G.R., Chi, L.H., Liang, Y., Gaile, D.P., Hu, Z., Crans, D.C., Diabetes-altered gene expression in rat skeletal muscle corrected to oral administration of vanadyl sulfate. Physiol. Genomics 26 (2006), 192–201.
49. Zang, Y., Liu, D., Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur. J. Pharmacol. 670 (2011), 325–332.